Xia Ding

机构：Beijing University of Chinese Medicine, Shanghai Jiao Tong University, Shanghai Ninth People's Hospital, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine · ORCID：0000-0003-0388-5388

发表论文 71 篇 · 总被引 3593 次 · h-index 29

代表论文

• A two-step mechanism governing PARP1-DNA retention by PARP inhibitors (2022 · Science Advances · 被引 49)
• ROS Responsive Cerium Oxide Biomimetic Nanoparticles Alleviates Calcium Oxalate Crystals Induced Kidney Injury via Suppressing Oxidative Stress and M1 Macrophage Polarization (2024 · Small · 被引 38)
• Circular RNAs in prostate cancer: Biogenesis, biological functions, and clinical significance (2021 · Molecular Therapy — Nucleic Acids · 被引 36)
• FBXW2 inhibits prostate cancer proliferation and metastasis via promoting EGFR ubiquitylation and degradation (2022 · Cellular and Molecular Life Sciences · 被引 31)
• Thermosensitive Resiquimod-Loaded Lipid Nanoparticles Promote the Polarization of Tumor-Associated Macrophages to Enhance Bladder Cancer Immunotherapy (2025 · ACS Nano · 被引 28)
• METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5/CCL5 regulation (2025 · Journal for ImmunoTherapy of Cancer · 被引 19)